Autophagy: a new target for nonalcoholic fatty liver disease therapy

Yuqing Mao,1 Fujun Yu,1 Jianbo Wang,2 Chuanyong Guo,3 Xiaoming Fan1 1Department of Gastroenterology and Hepatology, Jinshan Hospital of Fudan University, Shanghai, 2Department of Gastroenterology and Hepatology, The Central Hospital of Lishui City, Wenzhou Medical University, Zhejiang, 3Department o...

Full description

Bibliographic Details
Main Authors: Mao YQ, Yu FJ, Wang JB, Guo CY, Fan XM
Format: Article
Language:English
Published: Dove Medical Press 2016-03-01
Series:Hepatic Medicine : Evidence and Research
Subjects:
Online Access:https://www.dovepress.com/autophagy-a-new-target-for-nonalcoholic-fatty-liver-disease-therapy-peer-reviewed-article-HMER
id doaj-43c0996ee8ac44409b83bf36210489ed
record_format Article
spelling doaj-43c0996ee8ac44409b83bf36210489ed2020-11-24T21:57:53ZengDove Medical PressHepatic Medicine : Evidence and Research1179-15352016-03-012016Issue 1273726153Autophagy: a new target for nonalcoholic fatty liver disease therapyMao YQYu FJWang JBGuo CYFan XMYuqing Mao,1 Fujun Yu,1 Jianbo Wang,2 Chuanyong Guo,3 Xiaoming Fan1 1Department of Gastroenterology and Hepatology, Jinshan Hospital of Fudan University, Shanghai, 2Department of Gastroenterology and Hepatology, The Central Hospital of Lishui City, Wenzhou Medical University, Zhejiang, 3Department of Gastroenterology and Hepatology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China Abstract: Nonalcoholic fatty liver disease (NAFLD) has gained importance in recent decades due to drastic changes in diet, especially in Western countries. NAFLD occurs as a spectrum from simple hepatic steatosis, steatohepatitis to cirrhosis, and even hepatocellular carcinoma. Although the molecular mechanisms underlying the development of NAFLD have been intensively investigated, many issues remain to be resolved. Autophagy is a cell survival mechanism for disposing of excess or defective organelles, and has become a hot spot for research. Recent studies have revealed that autophagy is linked to the development of NAFLD and regulation of autophagy has therapeutic potential. Autophagy reduces intracellular lipid droplets by enclosing them and fusing with lysosomes for degradation. Furthermore, autophagy is involved in attenuating inflammation and liver injury. However, autophagy is regarded as a double-edged sword, as it may also affect adipogenesis and adipocyte differentiation. Moreover, it is unclear as to whether autophagy protects the body from injury or causes diseases and even death, and the association between autophagy and NAFLD remains controversial. This review is intended to discuss, comment, and outline the progress made in this field and establish the possible molecular mechanism involved. Keywords: nonalcoholic fatty liver disease, autophagy, steatosis, steatohepatitis, fibrosis, carcinogenesishttps://www.dovepress.com/autophagy-a-new-target-for-nonalcoholic-fatty-liver-disease-therapy-peer-reviewed-article-HMERnonalcoholic fatty liver diseaseautophagysteatosissteatohepatitisfibrosiscarcinogenesis
collection DOAJ
language English
format Article
sources DOAJ
author Mao YQ
Yu FJ
Wang JB
Guo CY
Fan XM
spellingShingle Mao YQ
Yu FJ
Wang JB
Guo CY
Fan XM
Autophagy: a new target for nonalcoholic fatty liver disease therapy
Hepatic Medicine : Evidence and Research
nonalcoholic fatty liver disease
autophagy
steatosis
steatohepatitis
fibrosis
carcinogenesis
author_facet Mao YQ
Yu FJ
Wang JB
Guo CY
Fan XM
author_sort Mao YQ
title Autophagy: a new target for nonalcoholic fatty liver disease therapy
title_short Autophagy: a new target for nonalcoholic fatty liver disease therapy
title_full Autophagy: a new target for nonalcoholic fatty liver disease therapy
title_fullStr Autophagy: a new target for nonalcoholic fatty liver disease therapy
title_full_unstemmed Autophagy: a new target for nonalcoholic fatty liver disease therapy
title_sort autophagy: a new target for nonalcoholic fatty liver disease therapy
publisher Dove Medical Press
series Hepatic Medicine : Evidence and Research
issn 1179-1535
publishDate 2016-03-01
description Yuqing Mao,1 Fujun Yu,1 Jianbo Wang,2 Chuanyong Guo,3 Xiaoming Fan1 1Department of Gastroenterology and Hepatology, Jinshan Hospital of Fudan University, Shanghai, 2Department of Gastroenterology and Hepatology, The Central Hospital of Lishui City, Wenzhou Medical University, Zhejiang, 3Department of Gastroenterology and Hepatology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China Abstract: Nonalcoholic fatty liver disease (NAFLD) has gained importance in recent decades due to drastic changes in diet, especially in Western countries. NAFLD occurs as a spectrum from simple hepatic steatosis, steatohepatitis to cirrhosis, and even hepatocellular carcinoma. Although the molecular mechanisms underlying the development of NAFLD have been intensively investigated, many issues remain to be resolved. Autophagy is a cell survival mechanism for disposing of excess or defective organelles, and has become a hot spot for research. Recent studies have revealed that autophagy is linked to the development of NAFLD and regulation of autophagy has therapeutic potential. Autophagy reduces intracellular lipid droplets by enclosing them and fusing with lysosomes for degradation. Furthermore, autophagy is involved in attenuating inflammation and liver injury. However, autophagy is regarded as a double-edged sword, as it may also affect adipogenesis and adipocyte differentiation. Moreover, it is unclear as to whether autophagy protects the body from injury or causes diseases and even death, and the association between autophagy and NAFLD remains controversial. This review is intended to discuss, comment, and outline the progress made in this field and establish the possible molecular mechanism involved. Keywords: nonalcoholic fatty liver disease, autophagy, steatosis, steatohepatitis, fibrosis, carcinogenesis
topic nonalcoholic fatty liver disease
autophagy
steatosis
steatohepatitis
fibrosis
carcinogenesis
url https://www.dovepress.com/autophagy-a-new-target-for-nonalcoholic-fatty-liver-disease-therapy-peer-reviewed-article-HMER
work_keys_str_mv AT maoyq autophagyanewtargetfornonalcoholicfattyliverdiseasetherapy
AT yufj autophagyanewtargetfornonalcoholicfattyliverdiseasetherapy
AT wangjb autophagyanewtargetfornonalcoholicfattyliverdiseasetherapy
AT guocy autophagyanewtargetfornonalcoholicfattyliverdiseasetherapy
AT fanxm autophagyanewtargetfornonalcoholicfattyliverdiseasetherapy
_version_ 1725853051969863680